Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsWorldHikma to buy Boehringer's US generics unit for $2.65 bn

    Hikma to buy Boehringer's US generics unit for $2.65 bn

    Hikma said it will pay about USD 1.18 billion in cash and issue 40 million new Hikma shares, or about 16.71 percent of its issued share capital, for Boehringer's Roxane Laboratories Inc and Boehringer Ingelheim Roxane Inc on closing of the deal.

    July 28, 2015 / 13:05 IST

    Hikma Pharmaceuticals Plc said it would buy German drugmaker Boehringer Ingelheim's US specialty generic drugs business for about USD 2.65 billion in cash and stock to bolster its presence in the United States.


    Hikma said it will pay about USD 1.18 billion in cash and issue 40 million new Hikma shares, or about 16.71 percent of its issued share capital, for Boehringer's Roxane Laboratories Inc and Boehringer Ingelheim Roxane Inc on closing of the deal.


    The company said the deal valuation was based on an agreed issue price for the new Hikma shares of 23.50 pounds per share and an exchange rate of 1.56 dollars to the pound.


    Hikma has also agreed to make milestone payments of up to USD 125 million.

    first published: Jul 28, 2015 01:05 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347